The efficacy and safety of indobufen in patients with ischemic cardiovascular or cerebrovascular diseases: systematic review and meta-analysis
ObjectiveThis meta-analysis aims to evaluate the safety and efficacy of indobufen in the treatment of cardiovascular diseases, cerebrovascular diseases, and thromboembolic disorders. The primary focus is on the incidence of major adverse cardiovascular events (MACE), thrombosis, bleeding events, and...
Saved in:
Main Authors: | Xiaolu Luo, Chenglu Lai, Tielong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1509010/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complications and Mortality Characterization in Acute Ischemic Cerebrovascular Disease
by: Ricardo Leyva Tornés, et al.
Published: (2021-09-01) -
Amphetamine use as a predictor of cardiovascular and cerebrovascular mortality and morbidity: a longitudinal cohort study of criminal justice clients
by: Ada Åhman, et al.
Published: (2025-01-01) -
Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province
by: Jia Wang, et al.
Published: (2025-01-01) -
Characterization of patients with ischemic cerebrovascular disease and cognitive impairment. Cienfuegos, 2018
by: Beatriz Perdomo Borges, et al.
Published: (2020-05-01) -
Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis
by: Biqiong Pan, et al.
Published: (2025-02-01)